Tyson Rossi - 10 Jan 2022 Form 3 Insider Report for MedMen Enterprises, Inc.

Role: Ch. Strategy Officer
Signature: /s/ Tyson Rossi
Issuer symbol: N/A
Transactions as of: 10 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 26 Jan 2022, 18:08:51 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MMNFF	Class B Subordinate Voting Shares						13,277	10 Jan 2022	Direct	F1
holding	MMNFF	Class B Subordinate Voting Shares						262,971	10 Jan 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MMNFF	Employee Stock Options (right to buy)							10 Jan 2022	Class B Subordinate Voting Shares	10,000	$1.99	Direct	F3, F4
holding	MMNFF	Employee Stock Options (right to buy)							10 Jan 2022	Class B Subordinate Voting Shares	4,530	$0.1670	Direct	F3, F5
holding	MMNFF	Employee Stock Options (right to buy)							10 Jan 2022	Class B Subordinate Voting Shares	66,213	$0.2814	Direct	F3, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"), granted 9/9/2020 pursuant to Issuer's 2018 Stock and Incentive Plan (the "Incentive Plan"), which vest annually over four years with 37.5% vesting on 6/30/2021 and 6/30/2023, and 12.5% vesting on 6/30/2022 and 6/30/24. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.
F2	Represents RSUs granted 8/29/2021 pursuant to the Incentive Plan, which vest annually over four years with 37.5% vesting on 6/30/2022 and 6/30/2024, and 12.5% vesting on 6/30/2023 and 6/30/25. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.
F3	Employee stock options (right to buy) ("Options") granted pursuant to the Incentive Plan.
F4	Options have an exercise price of CAN$2.64, which is equivalent to US$1.9858 at an exchange rate of 0.7522 as of the grant date.
F5	Options have an exercise price of CAN$0.22, which is equivalent to US$0.1670 at an exchange rate of 0.7591 as of the grant date.
F6	Options have an exercise price of CAN$0.355, which is equivalent to US$0.2814 at an exchange rate of 0.7925 as of the grant date.